🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/08/2002 | 6,68 | 6,83 | 6,60 | 6,80 | +0,00% | 3,37% | 147.800 |
| 19/08/2002 | 6,71 | 6,80 | 6,71 | 6,80 | +0,67% | 1,42% | 443.000 |
| 16/08/2002 | 6,50 | 6,79 | 6,50 | 6,76 | +3,45% | 4,46% | 474.600 |
| 15/08/2002 | 6,70 | 6,70 | 6,42 | 6,53 | -0,31% | 4,18% | 245.200 |
| 14/08/2002 | 6,33 | 6,70 | 5,96 | 6,55 | +2,34% | 11,69% | 453.600 |
| 13/08/2002 | 6,68 | 6,76 | 6,33 | 6,40 | -4,83% | 6,44% | 274.200 |
| 12/08/2002 | 6,75 | 6,78 | 6,37 | 6,73 | -1,18% | 6,08% | 592.400 |
| 09/08/2002 | 6,43 | 6,82 | 6,38 | 6,81 | +1,34% | 6,93% | 583.800 |
| 08/08/2002 | 5,63 | 6,75 | 5,63 | 6,72 | +23,66% | 19,91% | 783.400 |
| 07/08/2002 | 5,50 | 6,22 | 5,23 | 5,43 | -1,36% | 18,11% | 1.382.200 |
| 06/08/2002 | 5,61 | 5,96 | 5,43 | 5,51 | -3,00% | 9,45% | 801.600 |
| 05/08/2002 | 6,06 | 6,08 | 5,61 | 5,68 | -6,20% | 7,76% | 245.400 |
| 02/08/2002 | 5,98 | 6,15 | 5,93 | 6,05 | +0,83% | 3,77% | 353.200 |
| 01/08/2002 | 6,15 | 6,25 | 5,80 | 6,00 | -1,23% | 7,32% | 893.600 |
| 31/07/2002 | 6,00 | 6,23 | 5,60 | 6,08 | +0,75% | 10,42% | 569.400 |
| 30/07/2002 | 5,87 | 6,55 | 5,85 | 6,03 | +0,50% | 11,93% | 155.000 |
| 29/07/2002 | 5,84 | 6,20 | 5,84 | 6,00 | +2,83% | 6,26% | 310.000 |
| 26/07/2002 | 5,73 | 5,90 | 5,73 | 5,84 | +0,26% | 2,97% | 120.000 |
| 25/07/2002 | 5,88 | 5,90 | 5,72 | 5,82 | -0,94% | 3,06% | 78.000 |
| 24/07/2002 | 5,50 | 5,88 | 5,45 | 5,88 | +6,72% | 7,82% | 1.019.600 |
| 23/07/2002 | 5,87 | 6,02 | 5,51 | 5,51 | -5,41% | 8,69% | 519.200 |
| 22/07/2002 | 5,73 | 6,00 | 5,72 | 5,82 | +0,69% | 4,89% | 142.000 |
| 19/07/2002 | 6,05 | 6,18 | 5,68 | 5,78 | -3,67% | 8,27% | 115.400 |
| 18/07/2002 | 6,12 | 6,16 | 5,95 | 6,00 | -1,23% | 3,52% | 412.400 |
| 17/07/2002 | 5,93 | 6,16 | 5,93 | 6,08 | +2,27% | 3,97% | 234.600 |
| 16/07/2002 | 5,56 | 5,95 | 5,48 | 5,94 | +6,55% | 8,54% | 258.400 |
| 15/07/2002 | 5,63 | 5,63 | 5,47 | 5,58 | -0,89% | 2,84% | 176.200 |
| 12/07/2002 | 5,33 | 5,65 | 5,33 | 5,63 | +4,07% | 6,10% | 143.400 |
| 11/07/2002 | 5,35 | 5,47 | 5,26 | 5,41 | +0,84% | 4,02% | 269.000 |
| 10/07/2002 | 5,68 | 5,74 | 5,28 | 5,36 | -5,38% | 8,11% | 221.800 |